Sareum Ltd. H1 Pretax Loss Narrows; Expects To Meet Market Expectations

LONDON (AFX) - Drug discover company Sareum Holdings PLC said its first-half pretax loss narrowed as it reported a three-fold increase in revenue for the period, adding that it looks forward to expanding the business while meeting the market's financial expectations.
MORE ON THIS TOPIC